--- title: "Alignment Healthcare (ALHC) Could Be 5% Below Fair Value As Strong Results Land" type: "News" locale: "en" url: "https://longbridge.com/en/news/291713071.md" description: "Alignment Healthcare (ALHC) is considered potentially undervalued by approximately 5%, trading at $23.80 against a fair value estimate of $24.92. This valuation follows strong quarterly results, including 33.3% revenue growth and better-than-expected earnings, which drove significant stock price momentum. The company's technology-enabled care model is expected to improve scalability and margins, though risks include Medicare Advantage policy changes and competitive pressures." datetime: "2026-07-05T04:11:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291713071.md) - [en](https://longbridge.com/en/news/291713071.md) - [zh-HK](https://longbridge.com/zh-HK/news/291713071.md) --- # Alignment Healthcare (ALHC) Could Be 5% Below Fair Value As Strong Results Land Recent investor interest in Alignment Healthcare (ALHC) has been driven by its latest quarterly report, which combined 33.3% year-on-year revenue growth, stronger than expected earnings per share, rapid membership gains, and higher Star Ratings across all member plans. See our latest analysis for Alignment Healthcare. Those quarterly results appear to have shifted sentiment, with a 30 day share price return of 54.85% and a 1 year total shareholder return of 75.39% pointing to strong recent momentum building on a very large 3 year total shareholder return. If Alignment Healthcare has put healthcare-backed growth on your radar, it may be worth seeing what else is moving and reviewing 40 healthcare AI stocks With Alignment Healthcare now trading close to analyst targets but still at a large discount to one intrinsic value estimate, investors face a key question: is this a genuine valuation gap or is the market already pricing in future growth? ## Most Popular Narrative: 4.5% Undervalued At a last close of $23.80 versus a narrative fair value of $24.92, Alignment Healthcare is framed as modestly undervalued, with that view resting heavily on how its model scales as membership grows. > _Alignment's robust, technology-enabled care model and investments in administrative automation, workflow standardization, and digital health platforms position the company to significantly lower SG&A expenses and improve scalability, likely powering both margin expansion and earnings growth over the next several years._ _Read the complete narrative._ Want to see what this narrative is really baking in for Alignment Healthcare? Revenue growth, margin lift, and a richer earnings base all sit at the core, with one valuation multiple doing most of the heavy lifting in the model. **Result: Fair Value of $24.92 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, Alignment Healthcare's narrative still hinges on Medicare Advantage policy remaining supportive, and competition not pushing acquisition costs or benefit spending higher than expected. Find out about the key risks to this Alignment Healthcare narrative. ## Next Steps Given this mix of optimism and concern around Alignment Healthcare, it makes sense to consider the full picture and move quickly to shape your own view using 4 key rewards and 1 important warning sign. ## Looking for more investment ideas beyond Alignment Healthcare? If Alignment Healthcare has sharpened your focus, do not stop here. The next smart move is widening your watchlist with curated ideas built from clear, transparent data. - Spot potential bargains early by scanning companies that combine quality with attractive pricing using the 44 high quality undervalued stocks. - Prioritize staying power by filtering for businesses with resilient finances through the solid balance sheet and fundamentals stocks screener (47 results). - Hunt for lesser known opportunities by tapping into the screener containing 18 high quality undiscovered gems before the crowd catches on. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [ALHC.US](https://longbridge.com/en/quote/ALHC.US.md) ## Related News & Research - [Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions](https://longbridge.com/en/news/293823088.md) - [Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation](https://longbridge.com/en/news/294115528.md) - [ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm](https://longbridge.com/en/news/293851575.md) - [21:43 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC](https://longbridge.com/en/news/293688125.md) - [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)